Bradley Pharmaceuticals INC
SEC CIK 864268 · NYSE: BDY · last insider filing 2008-02-21
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Murphy William J | Director | filed 2006 - 2008 |
| Hamot Seth W | Director | filed 2006 - 2008 |
| Fedida Andre DR | Director | filed 2006 - 2008 |
| Kriegsman Steven A | Director | filed 2006 - 2008 |
| Fedida Michael J | Director | filed 2006 - 2008 |
| Linton Douglas | Director | filed 2006 - 2008 |
| Glassman Daniel | Director · Pres. & CEO | filed 2006 - 2008 |
| Jacob Leonard S | Director | filed 2006 - 2007 |
| Glassman Iris | Director · Treasurer | filed 2006 - 2006 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Glassman Bradley | Senior VP - Sales & Marketing | filed 2007 - 2008 |
| Lenczycki R Brent | VP - CFO | filed 2008 - 2008 |
| Landau Ralph N | VP - Manufacturing | filed 2008 - 2008 |
| Goldstein Alan S | VP - Corporate Development | filed 2008 - 2008 |
| Renzo William A | VP Trade/Managed Care Relation | filed 2006 - 2006 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.